Diabetes drug could be key to halting glaucoma blindness
NCT ID NCT05426044
Summary
This study is testing if a common diabetes medication, metformin, can protect the optic nerve and slow vision loss in people with glaucoma. It will involve 125 glaucoma patients whose vision is getting worse despite standard treatment. Participants will take either metformin or a placebo pill daily for two years while doctors track changes in their eye nerve thickness and vision.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
HKU Eye Centre
RECRUITINGWong Chuk Hang, Hong Kong
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.